LBRX LB PHARMACEUTICALS INC
8-K Current Report
Filed: March 16, 2026
Health Care
Pharmaceutical PreparationsLB PHARMACEUTICALS INC (LBRX) 8-K current report filed with SEC EDGAR on March 16, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 5.02: Departure/Election of Directors or Officers
AI Filing Analysis8-K
Item 5.02 · Departure/Election of Directors or Officers
- • Zachary Prensky retiring from LBRX Board, not standing for reelection at 2026 Annual Meeting; no disagreement with company operations or policies
- • Prensky transitions to consulting role post-departure under amended Transition Agreement (originally dated Nov 26, 2024), effective June 3, 2026
Other LB PHARMACEUTICALS INC 8-K Filings
Get deeper insights on LB PHARMACEUTICALS INC
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.